Literature DB >> 8507184

A novel "active" form of proteasomes from Xenopus laevis ovary cytosol.

T Tokumoto1, K Ishikawa.   

Abstract

The cytosol fraction prepared from Xenopus laevis ovaries by one-step ultracentrifugation catalyzed the hydrolysis of succinyl-leucyl-leucyl-valyl-tyrosine-4-methylcoumaryl-7-amide with or without SDS, an activator of 20S latent proteasomes. Both activities were lost on immunodepletion with antibodies against 20S proteasome. Storage of the cytosol at 4 degrees C led to abolition of the SDS-independent activity, but not the SDS-dependent activity. Upon DEAE-cellulose chromatography, the enzyme catalyzing the SDS-independent activity could be separated from that responsible for the SDS-dependent activity. These results indicate that the ovary cytosol contains a large proportion of a novel, "active" form of proteasomes which does not require SDS but is unstable and is readily converted to a latent form which requires SDS. ATP is known to stabilize 26S protease complex, but ATP reduced SDS-independent activity. It seems that the "active" form of proteasomes (molecular weight: about 1000-kDa) is different from 26S protease complex.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8507184     DOI: 10.1006/bbrc.1993.1531

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  3 in total

1.  Protection from oxidative inactivation of the 20S proteasome by heat-shock protein 90.

Authors:  M Conconi; I Petropoulos; I Emod; E Turlin; F Biville; B Friguet
Journal:  Biochem J       Date:  1998-07-15       Impact factor: 3.857

2.  Initiation of cyclin B degradation by the 26S proteasome upon egg activation.

Authors:  T Tokumoto; M Yamashita; M Tokumoto; Y Katsu; R Horiguchi; H Kajiura; Y Nagahama
Journal:  J Cell Biol       Date:  1997-09-22       Impact factor: 10.539

3.  Regulated interaction between polypeptide chain elongation factor-1 complex with the 26S proteasome during Xenopus oocyte maturation.

Authors:  Toshinobu Tokumoto; Ayami Kondo; Junko Miwa; Ryo Horiguchi; Mika Tokumoto; Yoshitaka Nagahama; Noriyuki Okida; Katsutoshi Ishikawa
Journal:  BMC Biochem       Date:  2003-07-16       Impact factor: 4.059

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.